- Home
- DYN vs CSTM Comparison
DYN vs CSTM Comparison
Compare DYN & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- CSTM
- Stock Information
- Founded
- DYN 1984
- CSTM 2010
- Country
- DYN United States
- CSTM France
- Employees
- DYN N/A
- CSTM N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- CSTM Metal Fabrications
- Sector
- DYN Health Care
- CSTM Industrials
- Exchange
- DYN Nasdaq
- CSTM Nasdaq
- Market Cap
- DYN 1.4B
- CSTM 1.2B
- IPO Year
- DYN 2020
- CSTM 2013
- Fundamental
- Price
- DYN $9.57
- CSTM $13.43
- Analyst Decision
- DYN Strong Buy
- CSTM Buy
- Analyst Count
- DYN 15
- CSTM 3
- Target Price
- DYN $43.60
- CSTM $18.00
- AVG Volume (30 Days)
- DYN 2.7M
- CSTM 1.6M
- Earning Date
- DYN 08-11-2025
- CSTM 07-22-2025
- Dividend Yield
- DYN N/A
- CSTM N/A
- EPS Growth
- DYN N/A
- CSTM N/A
- EPS
- DYN N/A
- CSTM 0.50
- Revenue
- DYN N/A
- CSTM $7,434,000,000.00
- Revenue This Year
- DYN N/A
- CSTM $3.76
- Revenue Next Year
- DYN N/A
- CSTM $12.00
- P/E Ratio
- DYN N/A
- CSTM $27.23
- Revenue Growth
- DYN N/A
- CSTM N/A
- 52 Week Low
- DYN $6.36
- CSTM $7.33
- 52 Week High
- DYN $47.45
- CSTM $19.97
- Technical
- Relative Strength Index (RSI)
- DYN 32.17
- CSTM 61.70
- Support Level
- DYN $10.00
- CSTM $12.97
- Resistance Level
- DYN $10.74
- CSTM $13.36
- Average True Range (ATR)
- DYN 0.88
- CSTM 0.45
- MACD
- DYN -0.48
- CSTM -0.10
- Stochastic Oscillator
- DYN 0.53
- CSTM 62.98
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.